TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
270,267
|
280,772
|
338,609 |
| Earnings before taxes |
-19,482
|
42,404
|
103,340 |
| Total assets |
507,816
|
486,210
|
462,518 |
| Current assets |
136,533
|
160,840
|
195,190 |
| Current liabilities |
195,302
|
292,584
|
260,789 |
| Equity capital |
85,795
|
41,249
|
88,926 |
| - share capital |
5,744
|
5,750
|
5,763 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
16.9%
|
8.5%
|
19.2% |
| Turnover per employee |
772
|
802
|
967 |
| Profit as a percentage of turnover |
-7.2%
|
15.1%
|
30.5% |
| Return on assets (ROA) | |||
| Current ratio |
69.9%
|
55.0%
|
74.8% |
| Return on equity (ROE) |
-22.7%
|
102.8%
|
116.2% |
| Change turnover |
-10,237
|
-57,083
|
44,775 |
| Change turnover % |
-4%
|
-17%
|
15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.